ArticleBlood advances2022

Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data.

Mehdi Parviz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.